Navigation Links
Cardiome To Release 2007 Results
Date:3/24/2008

NASDAQ: CRME TSX: COM

VANCOUVER, March 24 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) today announced that it will report year-end 2007 financial results on the morning of Wednesday, March 26, 2008. Cardiome will hold a teleconference call and webcast at 9:00am Eastern (6:00am Pacific) on that day to discuss the results.

To access the conference call, please dial 416-641-6117 or 866-299-6655. There will be a separate dial-in line for analysts on which we will respond to questions at the end of the call. The webcast can be accessed through Cardiome's website at http://www.cardiome.com.

Webcast and telephone replays of the conference call will be available approximately two hours after the completion of the call through April 26, 2008. Please dial 416-695-5800 or 800-408-3053 and enter code 3256620 followed by the number sign to access the replay.

About Cardiome Pharma Corp.

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two late-stage clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), a Phase 1 program for GED-aPC, an engineered analog of recombinant human activated Protein C, and a pre-clinical program directed at improving cardiovascular function.

Vernakalant (iv) is the intravenous formulation of an investigational drug being evaluated for the acute conversion of atrial fibrillation. Positive top-line results from two pivotal Phase 3 trials for vernakalant (iv), called ACT 1 and ACT 3, were released in December 2004 and September 2005. Cardiome's co-development partner Astellas Pharma US, Inc. submitted a New Drug Application for vernakalant (iv) in December 2006. Positive top-line results from an additional Phase 3 study evaluating patients with post-operative atrial arrhythmia, called ACT 2, were released in June 2007. An open-label safety st
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
2. Cardiome And Astellas Announce Regulatory Update
3. Cardiome to Hold Investor Update Call
4. Cardiome Updates Guidance
5. Cardiome Initiates Phase 1 Study for GED-aPC
6. Cardiome To Release Third Quarter Results
7. Cardiome to Present at CIBC Conference
8. Cardiome to Present at ThinkEquity Conference
9. Cardiome to Present at Bear Stearns Conference
10. RxElite Inc. Fourth Quarter and Year-End 2007 Earnings Release and Conference Call Notice
11. National Report on Patient Perspectives of Hospital Care Released Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... CT (PRWEB) , ... August 01, 2015 , ... ... Point Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy & ... it into its portfolio of state-of-the-art clinics. , “Our acquisition of Premier Physical ...
(Date:8/1/2015)... ... ... “ reTXT ” was featured on NewsWatch as part of its monthly AppWatch, which ... Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the ... message including ones already sent. , While text messaging has more features than it ...
(Date:7/31/2015)... York, New York (PRWEB) , ... July 31, 2015 , ... ... to strut their stuff, Super-Sod debuted their new type of sod called Leisure ... registered trademark application in process. , To commemorate introduction of this new type of ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Precision Aesthetics is ... years. It was also the first provider of Exilis non-surgical fat reduction in ... after procedures it has attracted a large International clientele. Many patients travel to ...
(Date:7/31/2015)... GA (PRWEB) , ... July 31, 2015 , ... Sculpted ... , the CoolSmooth PRO this week. Zeltiq Aesthetics released this new applicator in ... in January 2014 for treating the outer thighs. The original applicator required a ...
Breaking Medicine News(10 mins):Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3
... Study Defining Mechanism,and Potential Treatment for Rett Syndrome, Leading ... trial to test molecule in humans is being planned ... to other forms of autism - , BOSTON ... research, clinical and family collaboration dedicated to radically accelerating ...
... 9 Immtech Pharmaceuticals, Inc. (NYSE Alternext: IMM) today ... 31, 2008.For the three months ended December 31, 2008, ... three months ended December 31, 2007. The decrease ... a research and testing agreement. Loss from operations ...
... The Emergency Nurses Association (ENA) today announced the corporate sponsors ... Nevada on March 4 - 8, 2009.This year,s sponsors are ... pleased that these two companies have chosen to support emergency ... ENA Leadership Conference," said William T. Briggs, RN, MSN, CEN, ...
... ANN ARBOR, Mich., Feb. 9 A research brief ... percent of children used,health services due to influenza-like illness ... than double the rate for adults. , ... children used healthcare,services for ILI than families without children ...
... of cardiovascular disease, cancer , , MONDAY, Feb. 9 (HealthDay ... supplement industry, researchers find no evidence that multivitamin use ... the top two killers of women, respectively. , "Women ... seem to do no harm, but they also seem ...
... & IVF Institute,s New SALUTE(TM) Program Honors Military FAIRFAX, Va., ... that it is offering special discounts on in vitro fertilization ... of the military who retired after at least twenty years ... a 25% per cycle discount on single cycles of in ...
Cached Medicine News:Health News:Autism Consortium members publish in PNAS: Mechanism, treatment for Rett syndrome -- top cause autism girls 2Health News:Autism Consortium members publish in PNAS: Mechanism, treatment for Rett syndrome -- top cause autism girls 3Health News:Immtech Reports Fiscal Third Quarter 2009 Results 2Health News:Immtech Reports Fiscal Third Quarter 2009 Results 3Health News:Emergency Nurses Association Announces Corporate Sponsors for Leadership Conference 2Health News:Kids and Their Families Are Hit Hardest During Flu Season, According to Thomson Reuters Study 2Health News:Vitamins Do Older Women Little Good 2Health News:Vitamins Do Older Women Little Good 3Health News:Special Discounts On Fertility Treatment For Active Duty and Retired Military 2
(Date:7/31/2015)... HILL, N.C. , July 31, 2015  In ... of customers who are increasingly mobile, increasingly connected, and ... a growing variety of customer interaction channels and tools ... technology, including social media. According to ... the over the counter (OTC) segment in a call ...
(Date:7/31/2015)... July 31, 2015 RnRMarketResearch.com ... market research report that provides an overview of ... data sourced from in-house databases, secondary and primary ... needles market products pipeline spread across 124 pages, ... 73 tables and 5 figures is now available ...
(Date:7/31/2015)... , July 31, 2015  Xcelience, a contract ... it has made a structured cash investment in ... specializing in milling, micronization and powder size classification ... grow Powdersize,s business while simultaneously adding a complete ... portfolio of capabilities. "As we ...
Breaking Medicine Technology:Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3
... 2011 /PRNewswire-Asia/ -- To expand our scope of services, ... establish a long-term business relationships with a city hospital in ... and clinics with more health-care equipment. Wuzhou Changlian ... with a local Chinese clinic, which puts a focus on ...
... new data published in Clinical Therapeutics , the ... impact on whether patients take it as prescribed. The ... Corp. (NYSE: MWV ), a provider of ... adherence behavior in patients when compared with traditional pill ...
Cached Medicine Technology:Shenzhen Wuzhou Changlian International Trading Co. Establishes Relationship with Hospital in Africa 2Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 2Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 3Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 4Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 5
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Ethicon Endo-Surgery provides disposable handheld instruments that provide reliable, precise performance every time. Our handheld instruments come in 5mm and 10mm sizes....
... Enhanced features including aspiration holes ... in laparoscopic procedures requiring precise dissection ... and increased suction demands. ,Flexible ... retractable and nonretractable electrodes and multiple ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: